| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4216054 | Revue des Maladies Respiratoires Actualités | 2012 | 5 Pages |
Abstract
The cardiovascular prognosis of sleep apnea syndrome (SAS) is still a major concern. In this field, looking for new markers results in the demonstration of nocturia as an important predictor of less reduction in blood pressure under CPAP, and suggests a role of an increased mean platelet volume in the pathogenesis of cardiovascular risk in obstructive sleep apnea patients. Adaptative pressure support servo-ventilation appears as the most efficient treatment in patients with chronic heart failure associated with Cheyne Stokes breathing.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
J.-C. Meurice,